Literature DB >> 14965167

A study of potential toxic effects after repeated 10-week administration of a new iron chelator--salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits.

Ivona Klimtová1, Tomás Simůnek, Yvona Mazurová, Jana Kaplanová, Martin Sterba, Radomír Hrdina, Vladimír Gersl, Michaela Adamcová, Premysl Ponka.   

Abstract

Salicylaldehyde Isonicotinoyl Hydrazone (SIH)--a Pyridoxal Isonicotinoyl Hydrazone (PIH) analogue--is an effective iron chelator with antioxidant and antimalarial effects, as documented in numerous in vitro studies. However, no toxicological data obtained from in vivo studies have been made available yet. In this study, the potential toxic effects of repeated administration of SIH (50 mg/kg, once weekly, 10 weeks, i.p.), partially dissolved in a 10% Cremophor solution, on various biochemical, haematological, and cardiovascular parameters and on morphology of selected tissues were investigated in rabbits. The obtained values were compared with data from the control (saline, 1 ml/kg, i.v.) and the Cremophor (10% Cremophor solution, 2 ml/kg, i.p.) groups. In this study, SIH did not induced marked signs of toxicity: No premature deaths occurred, the body weight increase was comparable with the control and Cremophor groups. Only few and mild changes in some biochemical and haematological parameters could be determined, most of them were noticed also in the control or Cremophor groups. The morphological changes in the kidney were mild and did not manifest in the biochemical examination. The cardiac function was also not affected markedly--the values of left ventricular ejection fraction and systolic time interval did not differ from the values of control group. Only an increased left ventricular contractility (dP/dtmax) was noticed in the SIH group at the end of the experiment as compared to the controls (13,354+/-1191 vs. 9339+/-647 mmHg/s, resp.). These results seem to be promising from the standpoint of possible clinical use of SIH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14965167

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  9 in total

Review 1.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

2.  LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).

Authors:  Jan Bureš; Hana Jansová; Ján Stariat; Tomáš Filipský; Přemysl Mladěnka; Tomáš Šimůnek; Radim Kučera; Jiří Klimeš; Qin Wang; Katherine J Franz; Petra Kovaříková
Journal:  J Pharm Biomed Anal       Date:  2014-12-03       Impact factor: 3.935

3.  Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.

Authors:  Nina Lukinova; Jared Iacovelli; Tzvete Dentchev; Natalie Wolkow; Allan Hunter; Defne Amado; Gui-Shuang Ying; Janet R Sparrow; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

4.  Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.

Authors:  Hana Jansová; Miloslav Macháček; Qin Wang; Pavlína Hašková; Anna Jirkovská; Eliška Potůčková; Filip Kielar; Katherine J Franz; Tomáš Simůnek
Journal:  Free Radic Biol Med       Date:  2014-06-30       Impact factor: 7.376

Review 5.  Iron homeostasis and toxicity in retinal degeneration.

Authors:  Xining He; Paul Hahn; Jared Iacovelli; Robert Wong; Chih King; Robert Bhisitkul; Mina Massaro-Giordano; Joshua L Dunaief
Journal:  Prog Retin Eye Res       Date:  2007-08-11       Impact factor: 21.198

6.  Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

Authors:  T Simůnek; M Sterba; O Popelová; H Kaiserová; M Adamcová; M Hroch; P Hasková; P Ponka; V Gersl
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

7.  Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.

Authors:  Eliška Potůčková; Kateřina Hrušková; Jan Bureš; Petra Kovaříková; Iva A Špirková; Kateřina Pravdíková; Lucie Kolbabová; Tereza Hergeselová; Pavlína Hašková; Hana Jansová; Miloslav Macháček; Anna Jirkovská; Vera Richardson; Darius J R Lane; Danuta S Kalinowski; Des R Richardson; Kateřina Vávrová; Tomáš Šimůnek
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 8.  Iron Accumulation and Lipid Peroxidation in the Aging Retina: Implication of Ferroptosis in Age-Related Macular Degeneration.

Authors:  Tantai Zhao; Xiaojian Guo; Yun Sun
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

9.  Schwann Cells Provide Iron to Axonal Mitochondria and Its Role in Nerve Regeneration.

Authors:  Bruno Siqueira Mietto; Priya Jhelum; Katrin Schulz; Samuel David
Journal:  J Neurosci       Date:  2021-07-16       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.